#BEGIN_DRUGCARD DB02975

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
2007-07-0

# ChEBI_ID:
Not Available

# Chemical_Formula:
C56H55N15O10S6

# Chemical_IUPAC_Name:
(2R)-1-{[(4R)-2-{2-[(18S,25S,35S)-35-[(S)-hydroxy(phenyl)methyl]-28-(methoxymethyl)-21-methyl-18-[(methylcarbamoyl)methyl]-16,23,30,33-tetraoxo-25-(propan-2-yl)-3,13,20,27,37-pentathia-7,17,24,31,34,39,40,41,42,43-decaazaheptacyclo[34.2.1.1^{2,5}.1^{12,15}.1^{19,22}.1^{26,29}.0^{6,11}]tritetraconta-1(38),2(43),4,6,8,10,12(42),14,19(41),21,26(40),28,36(39)-tridecaen-8-yl]-1,3-thiazol-4-yl}-4,5-dihydro-1,3-oxazol-4-yl]carbonyl}pyrrolidine-2-carboxamide

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Ge2270a

# HET_ID:
GEA

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C56H55N15O10S6/c1-24(2)39-55-70-42(36(87-55)19-80-5)47(77)59-17-38(73)67-43(44(74)26-10-7-6-8-11-26)54-66-34(23-85-54)52-63-31(20-83-52)41-27(50-64-32(21-82-50)46(76)61-29(16-37(72)58-4)53-69-40(25(3)86-53)48(78)68-39)13-14-28(60-41)51-65-33(22-84-51)49-62-30(18-81-49)56(79)71-15-9-12-35(71)45(57)75/h6-8,10-11,13-14,20-24,29-30,35,39,43-44,74H,9,12,15-19H2,1-5H3,(H2,57,75)(H,58,72)(H,59,77)(H,61,76)(H,67,73)(H,68,78)/t29-,30+,35+,39-,43-,44-/m0/s1

# InChI_Key:
InChIKey=JMDULECOHIXMNX-RGTZWTTFSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C12068

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2975

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
1290.52

# Molecular_Weight_Mono:
1289.258057195

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1D8T

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
3.99

# Predicted_LogS:
-5

# Predicted_Water_Solubility:
1.25e-02 g/l

# Primary_Accession_No:
DB02975

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936544

# PubChem_Substance_ID:
46508431

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01578

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CNC(=O)C[C@@H]1NC(=O)C2=CSC(=N2)C2=CC=C(N=C2C2=CSC(=N2)C2=CSC(=N2)[C@@H](NC(=O)CNC(=O)C2=C(COC)SC(=N2)[C@@H](NC(=O)C2=C(C)SC1=N2)C(C)C)[C@@H](O)C1=CC=CC=C1)C1=NC(=CS1)C1=N[C@H](CO1)C(=O)N1CCC[C@@H]1C(N)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:43 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE005674

# Drug_Target_1_GenBank_ID_Protein:
24053801

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
tufA

# Drug_Target_1_Gene_Sequence:
>1230 bp
TTAGCCCAGAACTTTAGCAACAACGCCCGCGCCAACGGTACGGCCGCCTTCACGGATTGC
GAAACGCAGACCGTCGTCCATCGCGATCGGGTGGATCAGGGTAACAACCATTTTGATGTT
GTCGCCCGGCATTACCATCTCTACGCCTTCCGGCAGTTCGATGGTACCAGTCACGTCAGT
AGTACGGAAGTAGAACTGCGGACGGTAGCCTTTGAAGAACGGAGTATGACGGCCGCCTTC
ATCTTTGGACAGAATGTACACTTCAGATTCGAACTTGGTGTGCGGCTTGATGGTGCCCGG
CTTAGCCAGTACCTGACCACGTTCGATTTCTTCACGTTTGATACCACGCAGCAGAACACC
TACGTTCTCACCAGCACGGCCTTCGTCCAGCAGTTTGCGGAACATTTCAACGCCAGTACA
GGTAGACTTCTGAGTCTCTTTGATACCAACGATTTCAACTTCTTCACCAACTTTGATGAT
ACCGCGTTCTACACGACCGGTAACAACGGTACCACGACCGGAGATGGAGAATACGTCTTC
GATCGGCAGCAGGAACGGCTTGTCAATCGCACGCTCTGGTTCCGGAATATAAGAATCCAG
GAAGCCAGCCAGTTCCAGGATTTTCGCTTCCCACTCTGCGTCGCCTTCCAGCGCTTTCAG
AGCAGAACCACGAACGATCGGAGTGTCGTCGCCCGGGAAGTCGTACTGAGACAGAAGTTC
ACGAACTTCCATTTCAACCAGTTCCAGCAGCTCTTCGTCATCAACCATGTCGCATTTGTT
CAGGAACACGATGATGTACGGAACGCCTACCTGACGACCCAGCAGGATGTGCTCACGAGT
CTGCGGCATCGGGCCGTCAGTCGCAGCAACTACCAGGATCGCGCCGTCCATCTGAGCAGC
ACCGGTGATCATGTTTTTAACATAGTCGGCGTGCCCCGGGCAGTCTACGTGTGCGTAGTG
ACGGGTCGGGGTGTCGTATTCAACGTGAGAAGTGTTGATGGTGATACCACGAGCTTTTTC
TTCCGGCGCGTTATCGATCTGGTCGAATGCGCGAGCAGCACCGCCGTAGGTTTTAGCCAG
TACGGTAGTGATTGCAGCGGTCAGCGTTGTTTTACCATGGTCAACGTGGCCGATAGTACC
GACGTTAACGTGCGGTTTTGTACGTTCAAACTTTTCTTTAGACACGGCTATATTCCTTAC
TATAGTGCTCTCCCCTTCAGGAGAGAGCAC

# Drug_Target_1_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_1_General_References:
12384590	Jin Q, Yuan Z, Xu J, Wang Y, Shen Y, Lu W, Wang J, Liu H, Yang J, Yang F, Zhang X, Zhang J, Yang G, Wu H, Qu D, Dong J, Sun L, Xue Y, Zhao A, Gao Y, Zhu J, Kan B, Ding K, Chen S, Cheng H, Yao Z, He B, Chen R, Ma D, Qiang B, Wen Y, Hou Y, Yu J: Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res. 2002 Oct 15;30(20):4432-41.
12704152	Wei J, Goldberg MB, Burland V, Venkatesan MM, Deng W, Fournier G, Mayhew GF, Plunkett G 3rd, Rose DJ, Darling A, Mau B, Perna NT, Payne SM, Runyen-Janecky LJ, Zhou S, Schwartz DC, Blattner FR: Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun. 2003 May;71(5):2775-86.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3396

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
43284

# Drug_Target_1_Name:
Elongation factor Tu

# Drug_Target_1_Number_of_Residues:
394

# Drug_Target_1_PDB_ID:
1D8T

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00009	GTP_EFTU
PF03143	GTP_EFTU_D3
PF03144	GTP_EFTU_D2

# Drug_Target_1_Protein_Sequence:
>Elongation factor Tu
MSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGAARAFDQIDNAPEEKARG
ITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHI
LLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALE
GDAEWEAKILELAGFLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVG
EEVEIVGIKETQKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGTIK
PHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMV
VTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
This protein promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of ribosomes during protein biosynthesis

# Drug_Target_1_SwissProt_ID:
Q83JC4

# Drug_Target_1_SwissProt_Name:
EFTU_SHIFL

# Drug_Target_1_Synonyms:
EF-Tu

# Drug_Target_1_Theoretical_pI:
5.14

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02975
